Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133304) titled 'Prediction model construction and multi center validation of transarterial therapy for hepatocellular carcinoma' on Sept. 24.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Guilin Medical University
Condition:
hepatocellular carcinoma (HCC)
Intervention:
transarterial chemoembolization,TACE:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: transarterial chemoembolization,TACE:450;hepatic arterial infusion chemotherapy,HAIC:450;
Countries of Recruitment:
China
To know more, visit ...